We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Financials 10.71%
3 Consumer Discretionary 10.62%
4 Healthcare 9.54%
5 Industrials 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DDS icon
1776
Dillards
DDS
$9.59B
$89K ﹤0.01%
493
-167
-25% -$21.5K
FXI icon
1777
iShares China Large-Cap ETF
FXI
$4.16B
$89K ﹤0.01%
1,929
+6
+0.3% +$277
UNM icon
1778
Unum
UNM
$14.7B
$89K ﹤0.01%
3,122
VREX icon
1779
Varex Imaging
VREX
$780M
$89K ﹤0.01%
3,308
YMAB
1780
DELISTED
Y-mAbs Therapeutics
YMAB
$89K ﹤0.01%
2,645
PFC
1781
DELISTED
Premier Financial Corp. Common Stock
PFC
$89K ﹤0.01%
3,134
AGYS icon
1782
Agilysys
AGYS
$3.25B
$88K ﹤0.01%
1,551
CHCT
1783
Community Healthcare Trust
CHCT
$433M
$88K ﹤0.01%
1,862
DNOW icon
1784
DNOW Inc
DNOW
$2.95B
$88K ﹤0.01%
9,243
DVAX
1785
DELISTED
Dynavax Technologies
DVAX
$88K ﹤0.01%
8,981
FGD icon
1786
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.6B
$88K ﹤0.01%
3,400
-250
-7% -$6.6K
GBIO
1787
DELISTED
Generation Bio
GBIO
$88K ﹤0.01%
328
HZO icon
1788
MarineMax
HZO
$1.15B
$88K ﹤0.01%
1,797
LUNG icon
1789
Pulmonx
LUNG
$92.8M
$88K ﹤0.01%
1,991
+1,018
+105% +$44.3K
PNTG icon
1790
Pennant Group
PNTG
$1.35B
$88K ﹤0.01%
2,149
TGI
1791
DELISTED
Triumph Group
TGI
$88K ﹤0.01%
4,259
RPT
1792
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$88K ﹤0.01%
6,804
COWN
1793
DELISTED
Cowen Inc. Class A Common Stock
COWN
$88K ﹤0.01%
2,148
ANGO icon
1794
AngioDynamics
ANGO
$647M
$87K ﹤0.01%
3,206
BSCT icon
1795
Invesco BulletShares 2029 Corporate Bond ETF
BSCT
$2.94B
$87K ﹤0.01%
4,106
+3,106
+311% +$65.2K
CSR
1796
Centerspace
CSR
$939M
$87K ﹤0.01%
1,104
GRPN icon
1797
Groupon
GRPN
$894M
$87K ﹤0.01%
2,006
LQD icon
1798
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.8B
$87K ﹤0.01%
651
+60
+10% +$7.91K
MATW icon
1799
Matthews International
MATW
$722M
$87K ﹤0.01%
2,426
-283
-10% -$11.3K
MDGL icon
1800
Madrigal Pharmaceuticals
MDGL
$11.7B
$87K ﹤0.01%
890
+103
+13% +$12.2K

Similar funds

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.